EUVIMEDEUVIMED entdecken
Crossref

Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers

Jun Tao, Chih-Jen Huang, Yu-Han Huang, Mei-Hung Pan, Mei-Hsuan Lee, Kelly J Yu, Kevin Wang, Bin Zhu iD, Allan Hildesheim, Chien-Jen Chen, Hwai-I Yang, Zhiwei Liu iD

Alimentary Pharmacology & Therapeutics · 2026-07 · 64 (2) · 222-234

DOI: 10.1111/apt.70678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 11.05.2026. Verfasst von Jun Tao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B, Chronic, Hepatitis B virus. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic hepatitis B virus (HBV) rarely leads to spontaneous hepatitis B surface antigen (HBsAg) seroclearance. However, host genetics contributing to this outcome remain poorly understood. We investigate genetic variants associated with HBsAg seroclearance and related viral markers.

Methods

We conducted GWAS in 3240 REVEAL‐HBV participants to identify SNPs/HLA variants associated with HBV DNA load, hepatitis B e antigen (HBeAg) seropositivity, and HBsAg level. Variants with suggestively pleiotropic effects ( p < 1 × 10 −5 ) were tested for association with spontaneous HBsAg seroclearance. The top variants ( p < 0.05) were evaluated in an independent Taiwan Biobank (TWB) cohort, comprising 11,340 HBsAg‐positive participants and 54,072 HBsAg‐negative but anti‐hepatitis B core antigen (anti‐HBc) positive participants.

Results

Among 535 spontaneous seroclearance and 2416 chronic HBV carriers in the REVEAL‐HBV cohort, we identified 91 SNPs through viral biomarkers. After linkage disequilibrium pruning, four candidates were tested for spontaneous seroclearance, among which two SNPs were significantly associated with seroclearance (rs148385846; nearby gene: CAMK1D ; OR = 0.60, p = 0.0047, and rs6906021; nearby gene: HLA‐DQB1 ; OR = 1.15, 95% CI = 1.01–1.32, p = 0.0363); and one (rs446717; nearby gene: CTNNB1 ) showed a marginal effect (OR = 1.15, 95% CI = 1.00–1.31, p = 0.0508). In TWB, associations for rs6906021 (OR = 1.22, 95% CI = 1.19–1.26, p = 2.53 × 10 −37 ) and rs446717 (OR = 1.03, 95% CI = 1.00–1.06, p = 0.04) were observed for early HBsAg seroclearance.

Conclusions

Although host genetic factors may influence HBV replication through immune‐mediated mechanisms, their impact on HBsAg levels is limited by its dual origin from cccDNA and integrated HBV DNA. These findings enhance understanding of host genetic contributions to HBV traits, though further research is needed to clarify their role in HBsAg seroclearance and guiding immunomodulatory therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHepatitis B, ChronicHepatitis B virusHumansFemalePolymorphism, Single NucleotideMaleMiddle AgedAdultGenome-Wide Association StudyBiomarkersTaiwanDNA, ViralCohort StudiesHepatitis B e AntigensViral Load

Stichwörter der Autor:innen

GWASchronic HBV infectionhepatitis B virushost geneticsseroclearance

Substanzen

Hepatitis B Surface AntigensBiomarkersDNA, ViralHepatitis B e Antigens

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Advanced Therapeutics Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-Sen University, Kaohsiung, Taiwan.
  • Agencia Costarriciense de Investigaciones Biologicas, San Jose, Costa Rica.

ORCID-Profile: Bin Zhu, Zhiwei Liu

Zitieren

APA

Tao, J., Huang, C. J., Huang, Y. H., Pan, M. H., Lee, M. H., Yu, K. J., Wang, K., Zhu, B., Hildesheim, A., Chen, C. J., Yang, H. I., & Liu, Z. (2026). Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers. Alimentary Pharmacology & Therapeutics, 64(2), 222-234. https://doi.org/10.1111/apt.70678

Vancouver

Tao J, Huang CJ, Huang YH, Pan MH, Lee MH, Yu KJ, et al. Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers. Alimentary Pharmacology & Therapeutics. 2026;64(2):222-234. doi:10.1111/apt.70678

BibTeX
@article{Tao2026,
  author = {Tao, Jun and Huang, Chih-Jen and Huang, Yu-Han and Pan, Mei-Hung and Lee, Mei-Hsuan and Yu, Kelly J and Wang, Kevin and Zhu, Bin and Hildesheim, Allan and Chen, Chien-Jen and Yang, Hwai-I and Liu, Zhiwei},
  title = {Genetic Determinants of Spontaneous Hepatitis B Surface Antigen Seroclearance and Its Associated Viral Markers},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {2},
  pages = {222--234},
  doi = {10.1111/apt.70678}
}
Kostenlos starten →